These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 32121394)
21. The immunomodulatory effects of TNF-α inhibitors on human Th17 cells via RORγt histone acetylation. Lin YC; Lin YC; Wu CC; Huang MY; Tsai WC; Hung CH; Kuo PL Oncotarget; 2017 Jan; 8(5):7559-7571. PubMed ID: 27926504 [TBL] [Abstract][Full Text] [Related]
22. The paradox of Th17 cell functions in tumor immunity. Asadzadeh Z; Mohammadi H; Safarzadeh E; Hemmatzadeh M; Mahdian-Shakib A; Jadidi-Niaragh F; Azizi G; Baradaran B Cell Immunol; 2017 Dec; 322():15-25. PubMed ID: 29103586 [TBL] [Abstract][Full Text] [Related]
23. The role and regulation of human Th17 cells in tumor immunity. Ye J; Livergood RS; Peng G Am J Pathol; 2013 Jan; 182(1):10-20. PubMed ID: 23159950 [TBL] [Abstract][Full Text] [Related]
24. Epigenetic activation during T helper 17 cell differentiation is mediated by Tripartite motif containing 28. Jiang Y; Liu Y; Lu H; Sun SC; Jin W; Wang X; Dong C Nat Commun; 2018 Apr; 9(1):1424. PubMed ID: 29651155 [TBL] [Abstract][Full Text] [Related]
25. Role of interleukin (IL)-17 and T-helper (Th)17 cells in cancer. Song Y; Yang JM Biochem Biophys Res Commun; 2017 Nov; 493(1):1-8. PubMed ID: 28859982 [TBL] [Abstract][Full Text] [Related]
26. RORγt-specific transcriptional interactomic inhibition suppresses autoimmunity associated with TH17 cells. Park TY; Park SD; Cho JY; Moon JS; Kim NY; Park K; Seong RH; Lee SW; Morio T; Bothwell AL; Lee SK Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18673-8. PubMed ID: 25527718 [TBL] [Abstract][Full Text] [Related]
27. MBD2 regulates TH17 differentiation and experimental autoimmune encephalomyelitis by controlling the homeostasis of T-bet/Hlx axis. Zhong J; Yu Q; Yang P; Rao X; He L; Fang J; Tu Y; Zhang Z; Lai Q; Zhang S; Kuczma M; Kraj P; Xu JF; Gong F; Zhou J; Wen L; Eizirik DL; Du J; Wang W; Wang CY J Autoimmun; 2014 Sep; 53():95-104. PubMed ID: 24934598 [TBL] [Abstract][Full Text] [Related]
29. Epigenetic interplay between immune, stromal and cancer cells in the tumor microenvironment. Garcia-Gomez A; Rodríguez-Ubreva J; Ballestar E Clin Immunol; 2018 Nov; 196():64-71. PubMed ID: 29501540 [TBL] [Abstract][Full Text] [Related]
30. Differentiation stage-specific effect of histone deacetylase inhibitors on the expression of RORγT in human lymphocytes. Sałkowska A; Karaś K; Walczak-Drzewiecka A; Dastych J; Ratajewski M J Leukoc Biol; 2017 Dec; 102(6):1487-1495. PubMed ID: 28951421 [TBL] [Abstract][Full Text] [Related]
31. A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17(+) cell frequency. Punt S; Dronkers EA; Welters MJ; Goedemans R; Koljenović S; Bloemena E; Snijders PJ; Gorter A; van der Burg SH; Baatenburg de Jong RJ; Jordanova ES Cancer Immunol Immunother; 2016 Apr; 65(4):393-403. PubMed ID: 26899388 [TBL] [Abstract][Full Text] [Related]
32. A two-amino-acid substitution in the transcription factor RORγt disrupts its function in T He Z; Ma J; Wang R; Zhang J; Huang Z; Wang F; Sen S; Rothenberg EV; Sun Z Nat Immunol; 2017 Oct; 18(10):1128-1138. PubMed ID: 28846085 [TBL] [Abstract][Full Text] [Related]
33. Disturbed Th17/Treg Balance in Patients with Non-small Cell Lung Cancer. Duan MC; Han W; Jin PW; Wei YP; Wei Q; Zhang LM; Li JC Inflammation; 2015 Dec; 38(6):2156-65. PubMed ID: 26077695 [TBL] [Abstract][Full Text] [Related]
34. Tumor-infiltrating CD4+ Th17 cells produce IL-17 in tumor microenvironment and promote tumor progression in human gastric cancer. Iida T; Iwahashi M; Katsuda M; Ishida K; Nakamori M; Nakamura M; Naka T; Ojima T; Ueda K; Hayata K; Nakamura Y; Yamaue H Oncol Rep; 2011 May; 25(5):1271-7. PubMed ID: 21369705 [TBL] [Abstract][Full Text] [Related]
35. In vivo regulation of gene expression and T helper type 17 differentiation by RORγt inverse agonists. Skepner J; Trocha M; Ramesh R; Qu XA; Schmidt D; Baloglu E; Lobera M; Davis S; Nolan MA; Carlson TJ; Hill J; Ghosh S; Sundrud MS; Yang J Immunology; 2015 Jul; 145(3):347-56. PubMed ID: 25604624 [TBL] [Abstract][Full Text] [Related]
36. Targeting the interleukin-17 immune axis for cancer immunotherapy. Vitiello GA; Miller G J Exp Med; 2020 Jan; 217(1):. PubMed ID: 31727783 [TBL] [Abstract][Full Text] [Related]
37. Controversies on the role of Th17 in cancer: a TGF-β-dependent immunosuppressive activity? Martin F; Apetoh L; Ghiringhelli F Trends Mol Med; 2012 Dec; 18(12):742-9. PubMed ID: 23083809 [TBL] [Abstract][Full Text] [Related]
38. Molecular mechanisms of T helper 17 cell differentiation: Emerging roles for transcription cofactors. Jiang Y; Wang X; Dong C Adv Immunol; 2019; 144():121-153. PubMed ID: 31699215 [TBL] [Abstract][Full Text] [Related]
39. [Do Th17 cells play an important role in the pathogenesis and prognosis of ovarian cancer?]. Winkler I; Gogacz M; Rechberger T Ginekol Pol; 2012 Apr; 83(4):295-300. PubMed ID: 22712263 [TBL] [Abstract][Full Text] [Related]
40. T helper 17 (Th17) cells and interleukin-17 (IL-17) in cancer. Chang SH Arch Pharm Res; 2019 Jul; 42(7):549-559. PubMed ID: 30941641 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]